Premium Essay

Case Analysis: Sycamore Pharmaceuticals

In: Science

Submitted By Clark2015
Words 3372
Pages 14
Major Depression Disorder

Major Depression Disorde

The topic of this case study is Major Depression Disorder (MDD). This disorder is one of the most common psychiatric disorders, which occurs in both the young and old. Of all of the types of depression MDD is prominent due to the extent and duration of the most severe form of depression. It is second to heart disease in the extent it collaborates to the lower qualities of life. MDD is characterized by the effects it causes during such extent, leading it to be the most severe form of depression. In this paper the details of MDD, diagnosis, treatment, family, and psychosocial aspects will be covered. MDD as described by the DSM-IV TR is said to have 5 of the 9 disabling condition characteristics. Symptoms of MDD include but, are not limited to depressed mood, lack of interest, weight changes, sleep patterns, concentration issues, suicidal tendencies and thoughts. This disorder is characterized from other forms of depression such as seasonal affective disorder (SAD), and grief. For example, forms have less magnitude and shorter durations due to circumstantial situations related to the cause. MDD can be distinguished from other types of depression such as dysthymia and loss which, involve long-term chronic symptoms that do not disable and individual but, keep them from feeling good. The majestic of MDD can be conveyed by the social and occupational functioning. The downiness exemption to MDD need to be taken into consideration. Those individuals who are consumed with thoughts of death, antisocial, or lack of self would conclude a sever case. Unlike, severe MDD chronic MDD may last up to two years, whereas random cases of MDD are rare. The fundamental attributions of MDD shows there has been at least one case of MDD; with no signs of manic, confused, or hyperactivity. Thus, the…...

Similar Documents

Premium Essay

Case Analysis of Global Pharmaceuticals

...The Global Pharmaceutical Industry Case Analysis This case by Sarah Holland and Bernardo Bátiz-Lazostudies studies the evolution of the ethical pharmaceutical industry and analyses the various forces affecting the discovery, development, production, distribution and marketing of prescription drugs. The authors further analyses the critical issues of corporate social responsibility in the industry and the strategies being followed by major pharmaceutical companies and the challenges and opportunities for the future. This case bases its research to find evidence to support or disprove findings of a report published in the Gardiner by analysts at the investment bank of Dresdner Kleinwort Wasserstein which claimed that the world's major drugs companies are operating a business model that is unsustainable and rapidly running out of steam. On the surface however, the pharmaceuticals business seems like the epitome of a modern, mature industry that has found a comfortable way to make profits by the billion. According to the case large pharmaceuticals companies are currently facing the most challenging times since a decade. Even though the industry has made tremendous contributions to human well-being, its roles and actions are still criticized by the media and under constant scrutiny by national governments in their efforts to reduce expenditure in healthcare. Stringent laws and regulations have come in action which has made product approval, pricing and promotions......

Words: 6162 - Pages: 25

Premium Essay

Pestel Analysis of Pharmaceutical Industry

...A SWOT analysis identifies and assesses the strengths, weaknesses, opportunities and threats an organization faces. A SWOT analysis of the pharmaceutical industry illustrates to upper management what the industry is excelling in, what improvements need to be made, where growth is possible and what preemptive measures need to be taken to protect shareholder or company value. Strengths • The strengths of the pharmaceutical industry’s SWOT analysis document the internal industry components that are providing value, quality goods and services and overall excellence. The internal industry components can include physical resources, human capital or features the industry can control. For example, the pharmaceutical industry’s strengths could include low operating overhead, firm fiscal management, low staff turnover, high return on investment (ROI), state-of-the-art laboratory equipment and an experienced research staff. Weaknesses • The weaknesses of the pharmaceutical industry’s SWOT analysis document the internal industry components that are not providing significant added value or are in need of improvement. The internal industry components can include physical resources, human capital or features the industry can control. For example, the pharmaceutical industry’s weaknesses could include high-risk business modeling, disengaged Board of Directors, dated medical equipment, poor branding, low staff morale or diseconomies of scale. • Sponsored Links o viral clearance......

Words: 393 - Pages: 2

Premium Essay

Case Analysis Sycamore Pharmaceuticals

...John Blake and Cole Dominguez are both employed at Sycamore Pharmaceuticals. This case study is about the company manipulating scientific studies to say that the popular drug Osteoporin which is also used for rheumatoid arthritis was supposed to help the treatment of Crohn’s disease and lupus, but the scientific findings came back negative in helping with those two diseases. John Blake seems to be a genuine man and was truly feeling bad for not reporting the findings to anyone and keeping his mouth closed without letting anyone know. He was edgy, troubled and showing that he was repentant for taking part in this situation. Cole Dominguez was the complete opposite of those makings. He was more concerned with losing his next month’s bonus than feeling bad for the situation that had occurred. Both Blake and Dominguez had different views and attitudes towards how they were going to handle the scandal. Dominguez was going to stand by the manager no matter what in fear of losing his job in his defense he said he was only following orders. That may be true, but Dominguez showed no remorse or compassion for the patients that were affected by this situation. Dominguez thought that he was doing what he was told by the manager he would be not held responsible for the making of the scandal or situation which he was involved in. I will say that this showed his lack of personal ethical values and respect from the company. This would indicate that Dominguez is just as guilty as...

Words: 365 - Pages: 2

Premium Essay

Regal Pharmaceuticals Case Study

...REGAL PHARMACEUTICALS Regal pharmaceuticals is a reputed company and it is known for its proactive HR policies and practices. It is following a environmental friendly manufacturing activities to show they are contributing towards corporate social responsibility. The vision and mission of the company states the same. It is also doing some innovative HR practices in the company. But in spite of all these, pollution control board sent a show cause notice to the company because one of the manufacturing units are accused on account of pollution which affecting the nearby environment. This notice was quickly communicated to the public through electronic media. This resulted in losing the image of the company, of being socially responsible. Several campaigns which clarify the concern for the employment by the company are conducted by its PR managers. But even the employees were confused with the information from outside which made them doubt about the company’s vision and mission and the credibility of the top management. HR head organized personal meetings of the CMD and top executives with the employees in corporate offices as well as manufacturing locations. They created employee awareness groups, which were empowered to inspect the pollution control mechanism which is being implemented by them. The members of the EAG were counseled to tour the neighboring villages to create awareness about the responsible actions taken by the company. On the basis of the case I think...

Words: 352 - Pages: 2

Free Essay

Sycamore Pharmaceuticals

...DISCUSSION ONE: What are some examples of the physical and cognitive changes people go through when they enter late adult hood? a) Being that I am only 26 years old I have not experienced any of those life changing experience yet how ever what I can do is explain and describe that I have observed with my fellow co-wokers since I am the youngest person there. Like any person I do get curious what really qualifies you as a senior citizen, some of my fellow co-workers say when you hit 60 to 63 because that is when it all starts to go. When they stopped laughing I did notice a change of apperence in the sence of when they were telling me the things they use to do two, to three years ago and know they can not or even do it a bit slower, also in body weight. One of the things that I have noticed in my observation was that most men had complaints about hair loss and the further they get into there later adult hood the color there hair changes now some change to a whte color and some tuen to this violet white color it is what I have noticed. Unfortunatly my dad is one of those who lose there hair as they get older, at this point I fear for my hair and try to take care of it as best aas I can by not wearing hats and but shampoo that is pro hair growth.(Witt&Mossler,2010, health and Physical Development, page6. As observe other drivers I hear compolaints about things getting old meaning there internal organs are deteriorating and there not as they were when they were......

Words: 775 - Pages: 4

Premium Essay

Analysis of Case Study on Salix Pharmaceuticals

...Analysis of Case Study on Salix Pharmaceuticals, Inc Founded by two mutual acquaintances and former staff members of California Biotechnology Inc. (CalBio), Lorin Johnson and Randy Hamilton set out to build a company specializing in a specific area of need, such as inflammatory bowel disease. Their search throughout the international landscape was focused on the chemical compounds that would be the foundation for therapeutic drugs that serve as a benefit to the management gastric disorders. As these compounds were discovered by way of research, with the intent to align and contract with already licensed agreements if the price allows for the newly formed company to take part. One such compound that fit the need for the company was found at a research company in England by the name of Biorex. Johnson and Hamilton found that Biorex had a compound balsalazide disodium that was chemically similar in structure to salicin (found in the bark of the willow tree) that has been known to alleviate pain and fever. (Kyriazis and Swayne) After meeting with the Biorex representatives in the London headquarters, Salix was able to make an agreement to license their first product. Yet this opportunity had a big hurdle to overcome, since the business partners were working out of a spare bedroom and a limited capital of $9,500. It was necessary for the partners to gain the much needed capital to market their new and surround a team of sales personnel to get the word out. The team of Johnson...

Words: 722 - Pages: 3

Premium Essay

Case Analysis Teva Pharmaceuticals

...Teva Pharmaceutical Industries, Ltd 1) External Environment: The Pharmaceutical Industry is dependent on political and legal conditions of general environment. In pharmaceutical industry we have two kind of medications which are generic or innovative. Innovative pharmaceutical industry success depends on the patent protection in the industry. For example, in United States innovative industry can have 10 to 12 years of patent protection life from the time that product is for sale in the market. Success of the generic pharmaceuticals which are bioequivalent to innovative pharmaceutical is also related to the political and legal environment of their market. If we look at pharmaceutical industry globally we can see that regulations toward generic pharmaceutical are different in different countries. For example, in United States they have the Hatch-Waxman ACT 1984including Abbreviated New Drug Application which reduce the drugs approval period and give the chance to Generic companies to have a 180 day exclusivity period if the generic company can submit an abbreviated new drug application before other generic competitors. In Europe regulations are different in each country for example, United Kingdom and the Netherlands are very similar to USA, and countries such as Germany and France are more physician-driven or branded generics market and the cost of sale for generic products are higher in these countries. Market for generic drugs in the rest of...

Words: 1493 - Pages: 6

Premium Essay

Analysis of Indian Pharmaceutical Industry

... 1) Acknowledgement 2 2) Certificate of Authenticity 3 3) Research Objectives 5 4) Executive Summary 6 5) Chapter 1: Economic Analysis 7 6) Chapter 2: Industry Analysis 9 * Industry Life Cycle * Porters 5 Forces * SWOT * PESTLE * Correlation 7) Chapter 3: Company Analysis 24 * Company Profiles (10 Companies) * Financial Ratio Analysis * DCF Valuation * Valuation Shares 8) Conclusion 74 9) Bibliography 76 RESEARCH OBJECTIVES Research Project Topic: “Analysis and Valuation of the Indian Pharma Sector” The research objectives of this specialization project are: 1) Identifying the key indicators of the Global Pharma Industry 2) Understand and analyze the Indian Pharma Industry and identify the prominent players. 3) To examine the trends in the pharma industry 4) Fundamental and Technical Analyses of the Top 10......

Words: 11741 - Pages: 47

Free Essay

Porter Analysis for Pharmaceutical Industry in Palestine

...Porter’s Analysis: Pharmaceutical Industry | Submitted to Dr. Grace Khoury | By: Asem Masri. Student No. 1125420 | 11/6/2014 | 1. Contents Introduction 1 Porter’s Five Forces Analysis 1 Threat of new entrants 1 Rivalry among existing firms 2 Threat of substitute products 2 Bargaining power of buyers 3 Bargaining power of suppliers 4 Relative Power of other stakeholders 4 Conclusion 5 References 5 Introduction The pharmaceutical industry in Palestine is one of the most profitable industries, with the Palestinian companies owning 55% and 30% market share of the private and public sectors respectively, and high potential of growth even more, in a market estimated at around USD 100 million. All these companies mostly reproduce generics that are seen as commodities rather than differentiated, and highly depend on preferred agreements with pharmacies, doctors, hospitals and medical centers to serve both as their marketing and distribution channels. All operating firms in the industry are publicly traded companies, are highly controlled and regulated, depend heavily on technology and require vast financial resources. Because of the large size , high complexity and vast financial requirements of the industry, it won’t be a straight forward task to decide on whether this industry is attractive to enter or not, without performing proper STEEP and industry analysis. In this case, we will focus on performing pharmaceutical industry analysis using......

Words: 1927 - Pages: 8

Free Essay

Pestel Analysis of Pharmaceutical Industry

...treat­ ment of acetaminophen poisoning in man. Inhibition of Metabolic Activation Selective inhibition of the minor route of metabolism that generates the toxic metabolite of acetaminophen is an attractive possibility. However, safe effective inhibition of the metabolic activation of acetaminophen has not yet been investigated adequately in man and this approach has not been ex­ ploited clinically. Recent studies have shown that the acute toxicity of acetaminophen in animals is significantly reduced by cimetidine (42-44) and by acute administration of ethanol (45, 46). Protection was attributed 90 PRESCOIT & CRITCHLEY to inhibition of the metabolic activation of acetaminophen but other mecha­ nisms have not been excluded. In the case of ethanol, this hypothesis is supported by the observation that it significantly reduces the excretion of the mercapturic acid conjugate of acetaminophen in rats (46). In man, an acute ethanol load (1.72 g/Kg over 8 hours) markedly decreases the frac­ tion of an oral dose of 20 mglKg of acetaminophen excreted as the cysteine and mercapturic acid conjugates,but oral cimetidine in divided doses total­ ling 2 g over 16 hours has no such effect (J. A. J. H. Critchley and L. F. Annu. Rev. Pharmacol. Toxicol. 1983.23:87-101. Downloaded from www.annualreviews.org by Queen Mary & Westfield on 03/14/11. For personal use only. Prescott, unpublished). The protective effect of acute ethanol is of particular interest since chronic......

Words: 7818 - Pages: 32

Premium Essay

Industry Analysis of the Pharmaceutical Industry

...Corporate Development Strategies Faculty 02 – Economics and Business Administration Johann Wolfgang Goethe-University Frankfurt Industry analysis of the pharmaceutical industry Written assignment Submitted by: Heiko Kreuz, 4897736, s5706079@stud.uni-frankfurt.de Janine Seelinger, 4896818, s1010710@stud.uni-frankfurt.de Dana Winkler, 4497800, s1099437@stud.uni-frankfurt.de Supervisor: Prof. Dr. Lars Schweizer November 6, 2015 Table of contents 1 Introduction...........................................................................................................................1 2 Theoretical framework of Porter’s Five Forces ........................................................1 3 Industry analysis by means of Porter’s Five Forces ................................................2 3.1 Competitive rivalry ................................................................................................... 2 3.2 Bargaining power of suppliers.................................................................................. 2 3.3 Bargaining power of buyers ..................................................................................... 2 3.4 Threat of substitutes ................................................................................................. 3 3.5 Threat of new entrants .............................................................................................. 3 3.6 The regulators ............................

Words: 1934 - Pages: 8

Premium Essay

Case Mid Sized Pharmaceutical Company

...CASE STUDY 1 A Midsize Pharmaceutical Company Gido, Jack; Clements, James P. (2014-02-05). Successful Project Management (Page 58/59). Cengage Learning. Kindle Edition Jennifer Childs is the owner and chief executive officer of a midsize global pharmaceutical company with sales offices or manufacturing plants in eight countries. At an October staff meeting she tells her managers that company profits for the year are expected to be $2,000,000 more than anticipated. She tells them she would like to reinvest this additional profit by funding projects within the company that will either increase sales or reduce costs. She asks her three key managers to get together to develop a prioritized list of potential projects and then to meet with her to“sell”her on their ideas. She mentions that they should not assume the funds will be divided equally among the three of them. She also mentions that she is willing to put all of the funds into just one project if it seems appropriate. Julie Chen, manager of product development, has had a team of scientists working on a new prescription drug. This effort has been taking much longer than expected. She is worried that larger firms are working on a similar prescription drug and that these firms might get it to the marketplace first. Her team has not made any major breakthroughs yet, and some tests are not producing the expected results. She knows this is a risky project but feels that she cannot stop it now. Julie believes the company’s......

Words: 4639 - Pages: 19

Premium Essay

Merck and Lab Pharmaceuticals Case Study

...Business description In 2000 Merck is a successful pharmaceutical company with a handful of drugs developed internally as well as in joint-ventures. Its success however linked to the exclusivity rights of its patents, which makes its investors concerned about the close expiration (2002) of several patents of its blockbusters, which would dry out future revenues. The long-term viability of the company depends thus on the ability to refresh its portfolio of patent-protected drugs in order to counterbalance the loss of sales resulting from the generics. The large financial capacity of Merck & Co enables the company to buy rights to test, manufacture and market compounds which were generated by smaller companies which lack the capital or want to avoid the risk; in case the FDA is successfully completed Merck & Co. profits by having bought the patent at a cheap price. In this context a young pharma company, LAB Pharmaceuticals has approached Merck offering them to license one of their compounds called Davanrik. The company is in an uncomfortable financial situation and hesitates to launch the testing of this promising Davanrik, a drug whose use could be dual for weight and depression problems. Davanrik has already successfully completed the preclinical testing and has to complete the approval phases 1 to 3 and the final FDA approval. LAB proposed to Merck to be in charge of the approval of Davanrik, its manufacture and its marketing and would in exchange pay to LAB an initial fee,...

Words: 1029 - Pages: 5

Free Essay

Cambridge Sciences Pharmaceuticals Case Study

...The regrettable but unavoidable incidences of the very many cancers affecting people in Ireland today is an area of medicine which harnesses, in union with pharmaceutical products, the skills of Specialist Consultant Oncologists at the very highest level. Bayer is an established link in this chain principally through the proven use of its product Nexavar, which is currently licensed for the treatment of kidney and liver cancers. It is anticipated however that Nexavar’s scope will be extended to include its use in further indications in Oncology subject to positive phase III clinical trial results. All of this theatre of activity, from the viewpoints of the medical practitioners, the regulatory agencies and the pharmaceutical companies, is necessarily driven by the continuum of verified product trial statistical endpoints. While the market for pharmaceutically assisted weight-loss products is both extensive and growing, it remains fundamentally different from cancer therapies in that overweight individuals have realistically much more discretion with regard to the decision as to what if anything to choose from within the wide menu of discretionary weight-loss products, while cancer sufferers firstly must attend specialist Oncology consultants whose diagnostic analysis will determine what if any Oncology treatment may be suitable and secondly, being a life-threatening condition, cancer requires immediate urgent non-discretionary specialist care. While Nexavar currently is......

Words: 1504 - Pages: 7

Premium Essay

Case Analysis: Sycamore Pharmaceuticals

...Case Analysis: Sycamore Pharmaceuticals ABS 415: Leadership & Ethics in a Changing World May 25, 2012 John Blake and Cole Dominguez are both employed at Sycamore Pharmaceuticals. This case study is about the company manipulating scientific studies to say that the popular drug Osteoporin which is also used for rheumatoid arthritis was supposed to help the treatment of Crohn’s disease and lupus, but the scientific findings came back negative in helping with those two diseases. John Blake seems to be a sincere man and was truly feeling bad for not reporting the findings to anyone and keeping his mouth shut. He was nervous, upset and showing that he was remorseful for taking part in this situation. Cole Dominguez was the complete opposite of those qualities. He was more concerned with losing his next month’s quarterly bonus than feeling bad for the situation at hand. Each man had different views and attitudes towards how they were going to handle the scandal. Dominguez was going to stand by the manager no matter what in fear of losing his job in his defense he said he was only following orders. That may be true, but he showed no remorse or compassion for the patients that were affected by this situation. His philosophy was along as he did was he was told by the manager he would be not held responsible. This showed his lack of personal ethical values. He is just as guilty as the manager of concealing this information. He felt that......

Words: 1082 - Pages: 5